← Latest Viking Global portfolio

Viking Global portfolio · 2023-03-31

Form 13F reports holdings as of 2023-03-31 and was filed on 2023-05-15. It is delayed, can omit confidential positions, and is not the manager's current portfolio or fund NAV. Options show reported underlying value—not premium, net exposure, or investment intent.

Disclosed long book

$21.23 billion

Long positions

81

Calls / puts

0 / 0

Top 5 concentration

25.6%

Longs with AI data

0 / 81

Average AI 1Y

PositionKindSharesValueLong weightQuarter changeAI at filing · 1YAI now

VISA INC

VISA INC · COM CL A · 92826C839

LONG 6,560,069 $1.48 billion 7.0% INCREASED

1Y —

5Y —

MCKESSON CORP

MCKESSON CORP · COM · 58155Q103

LONG 3,207,080 $1.14 billion 5.4% INCREASED

1Y —

5Y —

UNITEDHEALTH GROUP INC

UNITEDHEALTH GROUP INC · COM · 91324P102

LONG 2,099,991 $992.4 million 4.7% INCREASED

1Y —

5Y —

ELEVANCE HEALTH INC

ELEVANCE HEALTH INC · COM · 036752103

LONG 2,154,556 $990.7 million 4.7% INCREASED

1Y —

5Y —

GENERAL ELECTRIC CO

GENERAL ELECTRIC CO · COM NEW · 369604301

LONG 8,612,232 $823.3 million 3.9% INCREASED

1Y —

5Y —

FORTINET INC

FORTINET INC · COM · 34959E109

LONG 11,875,384 $789.2 million 3.7% INCREASED

1Y —

5Y —

AMAZON COM INC

AMAZON COM INC · COM · 023135106

LONG 7,628,220 $787.9 million 3.7% REDUCED

1Y —

5Y —

API GROUP CORP

API GROUP CORP · COM STK · 00187Y100

LONG 34,090,285 $766.3 million 3.6% INCREASED

1Y —

5Y —

LULULEMON ATHLETICA INC

LULULEMON ATHLETICA INC · COM · 550021109

LONG 1,893,883 $689.7 million 3.2% NEWLY REPORTED

1Y —

5Y —

META PLATFORMS INC

META PLATFORMS INC · CL A · 30303M102

LONG 3,229,914 $684.5 million 3.2% INCREASED

1Y —

5Y —

CHUBB LTD SWITZ

CHUBB LTD SWITZ · COM · H1467J104

LONG 3,466,740 $673.2 million 3.2% REDUCED

1Y —

5Y —

CSX CORP

CSX CORP · COM · 126408103

LONG 22,057,119 $660.4 million 3.1% INCREASED

1Y —

5Y —

ROIVANT SCIENCES LTD

ROIVANT SCIENCES LTD · SHS · G76279101

LONG 88,238,700 $651.2 million 3.1% UNCHANGED

1Y —

5Y —

HDFC BANK LTD

HDFC BANK LTD · SPONSORED ADS · 40415F101

LONG 8,285,627 $552.4 million 2.6% REDUCED

1Y —

5Y —

INTUIT

INTUIT · COM · 461202103

LONG 1,221,094 $544.4 million 2.6% INCREASED

1Y —

5Y —

SHERWIN WILLIAMS CO

SHERWIN WILLIAMS CO · COM · 824348106

LONG 2,252,060 $506.2 million 2.4% NEWLY REPORTED

1Y —

5Y —

THERMO FISHER SCIENTIFIC INC

THERMO FISHER SCIENTIFIC INC · COM · 883556102

LONG 856,836 $493.9 million 2.3% INCREASED

1Y —

5Y —

BRIDGEBIO PHARMA INC

BRIDGEBIO PHARMA INC · COM · 10806X102

LONG 26,620,991 $441.4 million 2.1% UNCHANGED

1Y —

5Y —

FORTIVE CORP

FORTIVE CORP · COM · 34959J108

LONG 6,346,528 $432.6 million 2.0% INCREASED

1Y —

5Y —

ROYALTY PHARMA PLC

ROYALTY PHARMA PLC · SHS CLASS A · G7709Q104

LONG 11,204,249 $403.7 million 1.9% INCREASED

1Y —

5Y —

SEAGATE TECHNOLOGY HLDNGS PL

SEAGATE TECHNOLOGY HLDNGS PL · ORD SHS · G7997R103

LONG 5,513,957 $364.6 million 1.7% REDUCED

1Y —

5Y —

MICROSOFT CORP

MICROSOFT CORP · COM · 594918104

LONG 1,047,352 $302.0 million 1.4% REDUCED

1Y —

5Y —

MASTERCARD INCORPORATED

MASTERCARD INCORPORATED · CL A · 57636Q104

LONG 796,740 $289.5 million 1.4% REDUCED

1Y —

5Y —

AMERIPRISE FINL INC

AMERIPRISE FINL INC · COM · 03076C106

LONG 941,040 $288.4 million 1.4% REDUCED

1Y —

5Y —

KARUNA THERAPEUTICS INC

KARUNA THERAPEUTICS INC · COM · 48576A100

LONG 1,501,074 $272.7 million 1.3% INCREASED

1Y —

5Y —

ADAPTIVE BIOTECHNOLOGIES COR

ADAPTIVE BIOTECHNOLOGIES COR · COM · 00650F109

LONG 29,993,708 $264.8 million 1.2% UNCHANGED

1Y —

5Y —

VALVOLINE INC

VALVOLINE INC · COM · 92047W101

LONG 7,398,713 $258.5 million 1.2% INCREASED

1Y —

5Y —

ROGERS COMMS B

ROGERS COMMS B · COM · 775109200

LONG 5,554,500 $257.4 million 1.2% INCREASED

1Y —

5Y —

CADENCE DESIGN SYSTEM INC

CADENCE DESIGN SYSTEM INC · COM · 127387108

LONG 1,225,306 $257.4 million 1.2% INCREASED

1Y —

5Y —

ACADIA HEALTHCARE COMPANY IN

ACADIA HEALTHCARE COMPANY IN · COM · 00404A109

LONG 3,354,110 $242.3 million 1.1% INCREASED

1Y —

5Y —

BIOMARIN PHARMACEUTICAL INC

BIOMARIN PHARMACEUTICAL INC · COM · 09061G101

LONG 2,168,617 $210.9 million 1.0% REDUCED

1Y —

5Y —

EMERSON ELEC CO

EMERSON ELEC CO · COM · 291011104

LONG 2,400,879 $209.2 million 1.0% NEWLY REPORTED

1Y —

5Y —

GINKGO BIOWORKS HOLDINGS INC

GINKGO BIOWORKS HOLDINGS INC · CL A SHS · 37611X100

LONG 143,085,126 $190.3 million 0.9% INCREASED

1Y —

5Y —

MICRON TECHNOLOGY INC

MICRON TECHNOLOGY INC · COM · 595112103

LONG 2,856,599 $172.4 million 0.8% REDUCED

1Y —

5Y —

UNUM GROUP

UNUM GROUP · COM · 91529Y106

LONG 4,253,413 $168.3 million 0.8% INCREASED

1Y —

5Y —

ZOOMINFO TECHNOLOGIES INC

ZOOMINFO TECHNOLOGIES INC · COMMON STOCK · 98980F104

LONG 6,666,576 $164.7 million 0.8% NEWLY REPORTED

1Y —

5Y —

BLOCK INC

BLOCK INC · CL A · 852234103

LONG 2,354,123 $161.6 million 0.8% REDUCED

1Y —

5Y —

CONSTELLATION ENERGY CORP

CONSTELLATION ENERGY CORP · COM · 21037T109

LONG 2,047,688 $160.7 million 0.8% NEWLY REPORTED

1Y —

5Y —

MOLINA HEALTHCARE INC

MOLINA HEALTHCARE INC · COM · 60855R100

LONG 594,553 $159.0 million 0.7% INCREASED

1Y —

5Y —

PROGRESSIVE CORP

PROGRESSIVE CORP · COM · 743315103

LONG 1,003,562 $143.6 million 0.7% INCREASED

1Y —

5Y —

WORKDAY INC

WORKDAY INC · CL A · 98138H101

LONG 642,447 $132.7 million 0.6% NEWLY REPORTED

1Y —

5Y —

INHIBRX INC

INHIBRX INC · COM · 45720L107

LONG 6,639,199 $125.3 million 0.6% UNCHANGED

1Y —

5Y —

COUPANG INC

COUPANG INC · CL A · 22266T109

LONG 7,421,453 $118.7 million 0.6% NEWLY REPORTED

1Y —

5Y —

EQUITABLE HLDGS INC

EQUITABLE HLDGS INC · COM · 29452E101

LONG 3,989,446 $101.3 million 0.5% REDUCED

1Y —

5Y —

KBR INC

KBR INC · COM · 48242W106

LONG 1,679,474 $92.5 million 0.4% INCREASED

1Y —

5Y —

AMYLYX PHARMACEUTICALS INC

AMYLYX PHARMACEUTICALS INC · COM · 03237H101

LONG 2,962,555 $86.9 million 0.4% REDUCED

1Y —

5Y —

RIVIAN AUTOMOTIVE INC

RIVIAN AUTOMOTIVE INC · COM CL A · 76954A103

LONG 5,250,417 $81.3 million 0.4% NEWLY REPORTED

1Y —

5Y —

INSPIRE MED SYS INC

INSPIRE MED SYS INC · COM · 457730109

LONG 346,576 $81.1 million 0.4% REDUCED

1Y —

5Y —

GUARDANT HEALTH INC

GUARDANT HEALTH INC · NOTE 11/1 · 40131MAB5

LONG 120,000,000 $81.0 million UNCHANGED

1Y —

5Y —

CHARLES RIV LABS INTL INC

CHARLES RIV LABS INTL INC · COM · 159864107

LONG 394,089 $79.5 million 0.4% REDUCED

1Y —

5Y —

SYNOPSYS INC

SYNOPSYS INC · COM · 871607107

LONG 205,032 $79.2 million 0.4% NEWLY REPORTED

1Y —

5Y —

CATALENT INC

CATALENT INC · COM · 148806102

LONG 1,201,210 $78.9 million 0.4% REDUCED

1Y —

5Y —

ALKERMES PLC

ALKERMES PLC · SHS · G01767105

LONG 2,781,917 $78.4 million 0.4% NEWLY REPORTED

1Y —

5Y —

ZAI LAB LTD

ZAI LAB LTD · ADR · 98887Q104

LONG 2,331,245 $77.5 million 0.4% INCREASED

1Y —

5Y —

INTERNATIONAL FLAVORS&FRAGRA

INTERNATIONAL FLAVORS&FRAGRA · COM · 459506101

LONG 812,680 $74.7 million 0.4% INCREASED

1Y —

5Y —

4D MOLECULAR THERAPEUTICS IN

4D MOLECULAR THERAPEUTICS IN · COM · 35104E100

LONG 3,937,914 $67.7 million 0.3% UNCHANGED

1Y —

5Y —

TRAVELERS COMPANIES INC

TRAVELERS COMPANIES INC · COM · 89417E109

LONG 378,345 $64.9 million 0.3% NEWLY REPORTED

1Y —

5Y —

GUARDANT HEALTH INC

GUARDANT HEALTH INC · COM · 40131M109

LONG 2,538,889 $59.5 million 0.3% REDUCED

1Y —

5Y —

SNOWFLAKE INC

SNOWFLAKE INC · CL A · 833445109

LONG 382,757 $59.1 million 0.3% NEWLY REPORTED

1Y —

5Y —

INTELLIA THERAPEUTICS INC

INTELLIA THERAPEUTICS INC · COM · 45826J105

LONG 1,569,545 $58.5 million 0.3% REDUCED

1Y —

5Y —

BOSTON SCIENTIFIC CORP

BOSTON SCIENTIFIC CORP · COM · 101137107

LONG 1,136,881 $56.9 million 0.3% REDUCED

1Y —

5Y —

NEWAMSTERDAM PHARMA COMPANY

NEWAMSTERDAM PHARMA COMPANY · ORDINARY SHARES · N62509109

LONG 3,915,870 $52.6 million 0.2% INCREASED

1Y —

5Y —

COLGATE PALMOLIVE CO

COLGATE PALMOLIVE CO · COM · 194162103

LONG 660,698 $49.7 million 0.2% NEWLY REPORTED

1Y —

5Y —

DELL TECHNOLOGIES INC

DELL TECHNOLOGIES INC · CL C · 24703L202

LONG 1,094,394 $44.0 million 0.2% NEWLY REPORTED

1Y —

5Y —

CNH INDL N V

CNH INDL N V · SHS · N20944109

LONG 2,827,515 $43.2 million 0.2% NEWLY REPORTED

1Y —

5Y —

MARSH & MCLENNAN COS INC

MARSH & MCLENNAN COS INC · COM · 571748102

LONG 257,443 $42.9 million 0.2% NEWLY REPORTED

1Y —

5Y —

FARFETCH LTD

FARFETCH LTD · ORD SH CL A · 30744W107

LONG 7,103,457 $34.9 million 0.2% INCREASED

1Y —

5Y —

OPTION CARE HEALTH INC

OPTION CARE HEALTH INC · COM NEW · 68404L201

LONG 1,090,497 $34.6 million 0.2% NEWLY REPORTED

1Y —

5Y —

EDGEWISE THERAPEUTICS INC

EDGEWISE THERAPEUTICS INC · COM · 28036F105

LONG 4,909,146 $32.7 million 0.2% INCREASED

1Y —

5Y —

VIKING THERAPEUTICS INC

VIKING THERAPEUTICS INC · COM · 92686J106

LONG 1,955,063 $32.6 million 0.2% NEWLY REPORTED

1Y —

5Y —

TJX COS INC NEW

TJX COS INC NEW · COM · 872540109

LONG 414,401 $32.5 million 0.2% NEWLY REPORTED

1Y —

5Y —

PHARVARIS N V

PHARVARIS N V · COM · N69605108

LONG 3,231,923 $25.3 million 0.1% UNCHANGED

1Y —

5Y —

RALLYBIO CORP

RALLYBIO CORP · COM · 75120L100

LONG 4,194,777 $24.0 million 0.1% UNCHANGED

1Y —

5Y —

DAY ONE BIOPHARMACEUTICALS I

DAY ONE BIOPHARMACEUTICALS I · COM · 23954D109

LONG 1,558,563 $20.8 million 0.1% UNCHANGED

1Y —

5Y —

PEPGEN INC

PEPGEN INC · COM · 713317105

LONG 1,544,631 $18.9 million 0.1% UNCHANGED

1Y —

5Y —

KINNATE BIOPHARMA INC

KINNATE BIOPHARMA INC · COM · 49705R105

LONG 1,820,462 $11.4 million 0.1% UNCHANGED

1Y —

5Y —

TREVI THERAPEUTICS INC

TREVI THERAPEUTICS INC · COM · 89532M101

LONG 4,400,000 $8.1 million 0.0% UNCHANGED

1Y —

5Y —

LIANBIO

LIANBIO · SPONSORED ADS · 53000N108

LONG 3,564,173 $7.0 million 0.0% UNCHANGED

1Y —

5Y —

TALARIS THERAPEUTICS INC

TALARIS THERAPEUTICS INC · COM · 87410C104

LONG 3,289,617 $6.2 million 0.0% UNCHANGED

1Y —

5Y —

FIRST REP BK SAN FRANCISCO C

FIRST REP BK SAN FRANCISCO C · COM · 33616C100

LONG 276,260 $3.9 million 0.0% NEWLY REPORTED

1Y —

5Y —

VERASTEM INC

VERASTEM INC · COM · 92337C104

LONG 9,224,000 $3.8 million 0.0% UNCHANGED

1Y —

5Y —

AI outlook values are averages across the latest successful run per covered model at the labeled cutoff. “No longer reported” does not necessarily mean sold; thresholds, confidential treatment, corporate actions, or instrument changes may explain an omission. Reviewed API mapping covers 0.0% of disclosed long-book value; exact editorial CUSIP mappings may add current-only AI coverage on this public page. Research use only. No warranty and not investment advice.